课题基金 / 基金详情

Differential expression of CRP40 protein and its affects on dopamine-dependent behaviours and dopamine-activity

Differential expression of CRP40 protein and its affects on dopamine-dependent behaviours and dopamine-activity
CRP40蛋白的差异表达及其对多巴胺依赖性行为和多巴胺活性的影响
批准号:
355500-2009
负责人:
Gabriele, Joseph
金额:
$1.6万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2010
资助国家:
加拿大
项目状态:
已结题
起止时间:
2010-01-01 至 2011-12-31

项目摘要

项目成果

Gabriele, Joseph的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Catecholamines are neurotransmitters found in both the peripheral and central nervous system (CNS). CNS catecholamines consist of dopamine (DA) and its two hydroxylated products, norepinephrine, and epinephrenine. DA constitutes approximately 80% of catecholamines in the brain and, via its effects on specific receptors, is an important neurochemical mediator in behaviours. Likewise, aberrations in DA activity have been implicated in abnormal behaviour. Importantly, DA's effect in these domains is activity dependent and tightly coupled to extracellular DA levels in the synapse. However, relatively little is known about the molecular mechanisms that regulate levels of DA. The proposed research program seeks to investigate the role of a 40kDa catecholamine regulating protein (CRP40) in governing DA levels and, in turn, DA-dependent behaviour. This line of investigation is interesting given that my lab has shown that CRP40 is a multifunctional protein with catecholamine binding functions. Moreover, CRP40 may act as a scavenging molecule in the presence of excess DA activity. Arguably, these processes each represent potential components in the overall regulation of DA and bolster the suggestion that CRP40 has a fundamental impact on CNS DA levels and, consequently, DA-dependent behaviour. What is missing, however, are studies aimed at experimentally testing the impact of CRP40 manipulations on dopaminergic molecules causing alterations on DA concentrations, and DA-dependent behavior in order to elucidate these putative underlying relationships. The proposed approach in this research program will involve rat brain region specific knock-down of CRP40 mRNA in order to examine how the time-course of CRP40 knockdown and recovery is coupled to changes in several DA-dependent behaviours. Based on the hypothesis that CRP40 regulates DA activity, we predict that dysfunction and recovery of DA-dependent behaviours will follow the time-course of CRP40 protein recovery.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Differential expression of CRP40 protein and its affects on dopamine-dependent behaviours and dopamine-activity
  • 批准号:
    355500-2009
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $1.97万
  • 财政年份:
    2013
  • 负责人:
    Gabriele, Joseph
  • 依托单位:
Differential expression of CRP40 protein and its affects on dopamine-dependent behaviours and dopamine-activity
  • 批准号:
    355500-2009
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $1.97万
  • 财政年份:
    2012
  • 负责人:
    Gabriele, Joseph
  • 依托单位:
Differential expression of CRP40 protein and its affects on dopamine-dependent behaviours and dopamine-activity
  • 批准号:
    355500-2009
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $1.97万
  • 财政年份:
    2011
  • 负责人:
    Gabriele, Joseph
  • 依托单位:
Differential expression of CRP40 protein and its affects on dopamine-dependent behaviours and dopamine-activity
  • 批准号:
    355500-2009
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $1.6万
  • 财政年份:
    2009
  • 负责人:
    Gabriele, Joseph
  • 依托单位:
国内基金
海外基金
缺氧诱导因子(HIF)-2α转录抑制树突状细胞CD36表达减轻肾脏缺血再灌注损伤的机制
  • 批准号:
    82370751
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    张明
  • 依托单位:
内源性蛋白酶抑制剂SerpinA3N对缺血性脑卒中后血脑屏障的保护作用及其表达调控机制
  • 批准号:
    82371317
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    万杰清
  • 依托单位:
基于FCER1G基因介导免疫反应探讨迟发性聋与认知障碍相关性的机制研究
  • 批准号:
    82371141
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    陈颖
  • 依托单位:
22q11.2染色体微重复影响TOP3B表达并导致腭裂发生的机制研究
  • 批准号:
    82370906
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    代杰文
  • 依托单位: